Lack of oestrogen protection in amyloid-mediated endothelial damage due to protein nitrotyrosination

被引:37
作者
Coma, M
Guix, FX
Uribesalgo, I
Espuña, G
Solé, M
Andreu, D
Muñoz, FJ
机构
[1] Univ Pompeu Fabra, Lab Fisiol Mol, Unitat Senyalitzacio Cellular, Barcelona 08003, Spain
[2] Univ Pompeu Fabra, Unitat Proteom, Dept Ciencies Expt & Salut, Barcelona 08003, Spain
关键词
Alzheimer's disease; amyloid beta-peptide; oestrogen; nitric oxide; nitrotyrosination;
D O I
10.1093/brain/awh492
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Amyloid beta-peptide (A beta) cytotoxicity, the hallmark of Alzheimer's disease, implicates oxidative stress in both neurons and vascular cells, particularly endothelial cells. Consequently, antioxidants have shown neuroprotective activities against A beta-induced cytotoxicity. Among the different antioxidants used in both in vitro and in vivo studies, 17 beta-oestradiol (E-2) has garnered the most attention. Oestrogen attenuated A beta(E22Q)-induced toxicity in neurons but failed to protect endothelial cells. Here we show that E-2-mediated activation of endothelial nitric oxide synthase (eNOS) increases the production of nitric oxide (NO), which, under A beta(E22Q)-induced oxidative damage, results in the formation of peroxynitrite and increased nitration of tyrosine residues. Inhibition of eNOS prevents nitrotyrosination and permits E-2-mediated protection against A beta(E22Q) on endothelial cells. The main nitrotyrosinated proteins in the presence of E-2 and A beta(E22Q) were identified by MALDI-TOF mass spectrometry. These proteins are key players in the regulation of energy production, cytoskeletal integrity, protein metabolism and protection against oxidative stress. Our data highlight the potential damaging consequences of E-2 in vascular disorders dealing with oxidative stress conditions, such as cerebral amyloid angiopathy, stroke and ischaemia-reperfusion conditions.
引用
收藏
页码:1613 / 1621
页数:9
相关论文
共 46 条
  • [1] Increased formation of methylglyoxal and protein glycation, oxidation and nitrosation in triosephosphate isomerase deficiency
    Ahmed, N
    Battah, S
    Karachalias, N
    Babaei-Jadidi, R
    Horányi, M
    Baróti, K
    Hollan, S
    Thornalley, PJ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2003, 1639 (02): : 121 - 132
  • [2] ANTAGONISTIC ACTION OF IMIDAZOLINEOXYL N-OXIDES AGAINST ENDOTHELIUM-DERIVED RELAXING FACTOR .NO THROUGH A RADICAL REACTION
    AKAIKE, T
    YOSHIDA, M
    MIYAMOTO, Y
    SATO, K
    KOHNO, M
    SASAMOTO, K
    MIYAZAKI, K
    UEDA, S
    MAEDA, H
    [J]. BIOCHEMISTRY, 1993, 32 (03) : 827 - 832
  • [3] Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Alzheimer disease
    Aliev, G
    Smith, MA
    Obrenovich, ME
    De la Torre, JC
    Perry, G
    [J]. NEUROTOXICITY RESEARCH, 2003, 5 (07) : 491 - 504
  • [4] HYDROGEN-PEROXIDE MEDIATES AMYLOID-BETA PROTEIN TOXICITY
    BEHL, C
    DAVIS, JB
    LESLEY, R
    SCHUBERT, D
    [J]. CELL, 1994, 77 (06) : 817 - 827
  • [5] Oestrogen as a neuroprotective hormone
    Behl, C
    [J]. NATURE REVIEWS NEUROSCIENCE, 2002, 3 (06) : 433 - 442
  • [6] Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease
    Behl, C
    [J]. CELL AND TISSUE RESEARCH, 1997, 290 (03) : 471 - 480
  • [7] Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-amyloid complexes
    Bonnefort, AB
    Muñoz, FJ
    Inestrosa, NC
    [J]. FEBS LETTERS, 1998, 441 (02) : 220 - 224
  • [8] Alzheimer's amyloid β-peptide (1-42):: involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide
    Butterfield, DA
    Bush, AI
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 (05) : 563 - 568
  • [9] Butterfield DA, 1999, REV NEUROSCIENCE, V10, P141
  • [10] Proteomic identification of nitrated proteins in Alzheimer's disease brain
    Castegna, A
    Thongboonkerd, V
    Klein, JB
    Lynn, B
    Markesbery, WR
    Butterfield, DA
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 85 (06) : 1394 - 1401